Modus Therapeutics Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
MODTX
- Share Price
-
$0.13
- (As of Thursday Closing)
Modus Therapeutics General Information
Description
Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.
Contact Information
Website
www.modustx.comCorporate Office
- Olof Palmes gata 29 IV
- 111 22 Stockholm
- Sweden
Corporate Office
- Olof Palmes gata 29 IV
- 111 22 Stockholm
- Sweden
Modus Therapeutics Stock Performance
As of 17-Apr-2025, Modus Therapeutics’s stock price is $0.13. Its current market cap is $4.71M with 35.9M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.13 | $0.13 | $0.08 - $0.27 | $4.71M | 35.9M | 19.6K | -$0.04 |
Modus Therapeutics Financials Summary
As of 30-Sep-2024, Modus Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 4,752 | 7,578 | 3,653 | 3,464 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,400) | (1,543) | (1,775) | (2,409) |
| Net Income | (1,413) | (1,684) | (1,806) | (2,409) |
| Total Assets | 853 | 2,005 | 1,080 | 2,342 |
| Total Debt | 0 | 0 | 1,102 | 0 |
Modus Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Modus Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Modus Therapeutics Comparisons
Industry
Financing
Details
Modus Therapeutics Competitors (27)
One of Modus Therapeutics’s 27 competitors is Galectin Therapeutics, a Corporation company based in Norcross, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Galectin Therapeutics | Corporation | Norcross, GA | ||||
| Galecto | Formerly VC-backed | Copenhagen, Denmark | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Immunitas Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA |
Modus Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Modus Therapeutics Patents
Modus Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202314100-D0 | New medical use | Inactive | 15-Sep-2023 | ||
| GB-202302278-D0 | New medical use | Pending | 17-Feb-2023 | ||
| GB-2627263-A | New medical use | Pending | 17-Feb-2023 | ||
| GB-202219368-D0 | New medical use | Pending | 21-Dec-2022 | ||
| GB-2625581-A | New medical use | Pending | 21-Dec-2022 | A61K31/727 |
Modus Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Modus Therapeutics FAQs
-
When was Modus Therapeutics founded?
Modus Therapeutics was founded in 2004.
-
Where is Modus Therapeutics headquartered?
Modus Therapeutics is headquartered in Stockholm, Sweden.
-
What is the size of Modus Therapeutics?
Modus Therapeutics has 2 total employees.
-
What industry is Modus Therapeutics in?
Modus Therapeutics’s primary industry is Drug Discovery.
-
Is Modus Therapeutics a private or public company?
Modus Therapeutics is a Public company.
-
What is Modus Therapeutics’s stock symbol?
The ticker symbol for Modus Therapeutics is MODTX.
-
What is the current stock price of Modus Therapeutics?
As of 17-Apr-2025 the stock price of Modus Therapeutics is $0.13.
-
What is the current market cap of Modus Therapeutics?
The current market capitalization of Modus Therapeutics is $4.71M.
-
Who are Modus Therapeutics’s competitors?
Galectin Therapeutics, Galecto, Kite Pharma, Immunitas Therapeutics, and Sangamo Therapeutics are some of the 27 competitors of Modus Therapeutics.
-
What is Modus Therapeutics’s annual earnings per share (EPS)?
Modus Therapeutics’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
